{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:40:09Z","timestamp":1789090809641,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00745","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:17:43Z","timestamp":1571977063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior"],"prefix":"10.3389","volume":"10","author":[{"given":"Giovanna","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Giardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Treppiedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Mangili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Peverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-16-0452","article-title":"Novel genetic causes of pituitary adenomas","volume":"22","author":"Caimari","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to somatostatin analogs in acromegaly","volume":"32","author":"Colao","year":"2011","journal-title":"Endocrine Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"R223","DOI":"10.1530\/JME-14-0011","article-title":"Somatostatin receptor ligands and resistance to treatment in pituitary adenomas","volume":"52","author":"Cuevas-Ramos","year":"2014","journal-title":"J Mol Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1517\/14728214.2015.1047762","article-title":"Emerging drugs for Cushing's disease","volume":"20","author":"Guelho","year":"2015","journal-title":"Expert Opin Emerg Drugs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40842-015-0006-4","article-title":"Management of macroprolactinomas","volume":"1","author":"Tirosh","year":"2015","journal-title":"Clin Diabetes Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","article-title":"The longterm significance of microscopic dural invasion in 354 patients with pituitary tumors treated with transsphenoidal surgery","volume":"96","author":"Meiji","year":"2002","journal-title":"J Neurosurg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jocn.2012.01.038","article-title":"Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas","volume":"19","author":"Marko","year":"2012","journal-title":"J Clin Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","article-title":"Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence","volume":"108","author":"Losa","year":"2008","journal-title":"J Neurosurg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e5268","DOI":"10.1097\/MD.0000000000005268","article-title":"Genetic aspects of pituitary carcinoma: a systematic review","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-07-6691","article-title":"Wnt\/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","article-title":"The cancer stem cell: premises, promises and challenges","volume":"17","author":"Clevers","year":"2011","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene."},{"key":"B19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","article-title":"Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas","volume":"337","author":"Schepers","year":"2012","journal-title":"Science."},{"key":"B21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: the devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat. Rev. Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1158\/0008-5472.CAN-10-3220","article-title":"Cancer stem cell niche: the place to be","volume":"71","author":"Borovski","year":"2011","journal-title":"Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E2574","DOI":"10.3390\/ijms18122574","article-title":"drug resistance driven by cancer stem cells and their niche","volume":"18","author":"Prieto-Vila","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnmol.2019.00131","article-title":"Cancer stem cells in neuroblastoma: expanding the therapeutic frontier","volume":"12","author":"Bahmad","year":"2019","journal-title":"Front Mol Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5483\/bmbrep.2017.50.6.039","article-title":"Cancer stem cell surface markers on normal stem cells","volume":"50","author":"Kim","year":"2017","journal-title":"BMB Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells\u2014perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fonc.2018.00347","article-title":"Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem\/progenitor sphere-forming cells","volume":"8","author":"Bahmad","year":"2018","journal-title":"Front Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.stem.2013.08.001","article-title":"Continuous clonal labeling reveals small numbers of functional stem cells in intestinal crypts and adenomas","volume":"13","author":"Kozar","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature22081","article-title":"Visualization and targeting of LGR5+ human colon cancer stem cells","volume":"545","author":"Shimokawa","year":"2017","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12996","DOI":"10.1073\/pnas.1900251116","article-title":"Lineage tracing and targeting of IL17RB+ tuft cell-like human colorectal cancer stem cells","volume":"116","author":"Goto","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1182\/blood-2009-01-198911","article-title":"Differentiation therapy of leukemia: 3 decades of development","volume":"113","author":"Nowak","year":"2009","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","article-title":"Differentiation therapy revisited","volume":"18","author":"de Th\u00e9","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-18-2693","article-title":"ROCK inhibition induces terminal adipocyte differentiation and suppresses tumorigenesis in chemoresistant osteosarcoma cells","volume":"79","author":"Takahashi","year":"2019","journal-title":"Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fonc.2019.00207","article-title":"Genome-wide and phenotypic evaluation of stem cell progenitors derived from Gprc5a-deficient murine lung adenocarcinoma with somatic Kras mutations","volume":"9","author":"Daouk","year":"2019","journal-title":"Front Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"33549","DOI":"10.18632\/oncotarget.26088","article-title":"The Akt\/mTOR pathway in cancer stem\/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma","volume":"9","author":"Bahmad","year":"2018","journal-title":"Oncotarget."},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor \u03b1 chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell."},{"key":"B37","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-17-0258","article-title":"Stem\/progenitor cells in pituitary organ homeostasis and tumourigenesis","volume":"236","author":"Haston","year":"2018","journal-title":"J Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.bjc.6605142","article-title":"Isolation of tumour stem-like cells from benign tumours","volume":"101","author":"Xu","year":"2009","journal-title":"Br J Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2014.03.031","article-title":"Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma","volume":"349","author":"Chen","year":"2014","journal-title":"Cancer Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/ERC-14-0546","article-title":"Pituitary tumors contain a side population with tumor stem cell-associated characteristics","volume":"22","author":"Mertens","year":"2015","journal-title":"Endocr Relat Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-016-0394-4","article-title":"The identification of human pituitary adenoma-initiating cells","volume":"4","author":"Manoranjan","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","article-title":"Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas","volume":"54","author":"W\u00fcrth","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/ijc.30613","article-title":"Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor\/stem-like cells isolated from nonfunctioning pituitary tumors","volume":"140","author":"Peverelli","year":"2017","journal-title":"Int J Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fendo.2017.00339","article-title":"The stem cell connection of pituitary tumors","volume":"8","author":"Vankelecom","year":"2017","journal-title":"Front Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1210\/en.2005-0185","article-title":"The adult pituitary contains a cell population displaying stem\/progenitor cell and early embryonic characteristics","volume":"146","author":"Chen","year":"2005","journal-title":"Endocrinology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/stem.51","article-title":"Pituitary progenitor cells tracked down by side population dissection","volume":"27","author":"Chen","year":"2009","journal-title":"Stem Cells."},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/ERC-13-0229","article-title":"Sca1+ murine pituitary adenoma cells show tumor-growth advantage","volume":"21","author":"Donangelo","year":"2014","journal-title":"Endocr Relat Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncb2717","article-title":"Cancer stem cells: the challenges ahead","volume":"15","author":"Medema","year":"2013","journal-title":"Nat Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000330625","article-title":"Identification of CD133+ cells in pituitary adenomas","volume":"94","author":"Yunoue","year":"2011","journal-title":"Neuroendocrinology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EJE-16-0206","article-title":"Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists","volume":"175","author":"Greenman","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.canlet.2016.08.005","article-title":"Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation","volume":"381","author":"Peverelli","year":"2016","journal-title":"Cancer Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/ijc.31205","article-title":"A novel pathway activated by somatostatin receptor type 2 (SST2): inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment","volume":"142","author":"Peverelli","year":"2018","journal-title":"Int J Cancer."},{"key":"B53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11102-014-0553-1","article-title":"Expression of the pituitary stem\/progenitor marker GFR\u03b12 in human pituitary adenomas and normal pituitary","volume":"18","author":"Mathioudakis","year":"2015","journal-title":"Pituitary."},{"key":"B54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.surneu.2008.09.016","article-title":"Brain tumor stem cells: view from cell proliferation","volume":"71","author":"Yao","year":"2009","journal-title":"Surg Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e43996","DOI":"10.7554\/eLife.43996","article-title":"Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS\/YAP\/TAZ cascade","volume":"8","author":"Lodge","year":"2019","journal-title":"Elife."},{"key":"B56","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2013.07.004","article-title":"Sox2+ stem\/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential","volume":"13","author":"Andoniadou","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/stem.2267","article-title":"Concise review: paracrine role of stem cells in pituitary tumors: a focus on adamantinomatous craniopharyngioma","volume":"34","author":"Martinez-Barbera","year":"2016","journal-title":"Stem Cells."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:17:45Z","timestamp":1571977065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":57,"alternative-id":["10.3389\/fendo.2019.00745"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00745","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"article-number":"745"}}